In addition, a high concentration of DJ-1 can be detected in body fluids such as serum, pancreatic juice, and nipple fluid in patients with breast cancer, PDAC, melanoma, and Parkinson’s disease, suggesting that DJ-1 can act as a non-invasive biomarker for cancer diagnosis and prognosis2,4,5. This evidence concerns the gene PARK7 and breast carcinoma.